2018
DOI: 10.1186/s12951-018-0422-6
|View full text |Cite
|
Sign up to set email alerts
|

In vitro and in vivo accumulation of magnetic nanoporous silica nanoparticles on implant materials with different magnetic properties

Abstract: BackgroundIn orthopedic surgery, implant-associated infections are still a major problem. For the improvement of the selective therapy in the infection area, magnetic nanoparticles as drug carriers are promising when used in combination with magnetizable implants and an externally applied magnetic field. These implants principally increase the strength of the magnetic field resulting in an enhanced accumulation of the drug loaded particles in the target area and therewith a reduction of the needed amount and t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 14 publications
(18 citation statements)
references
References 62 publications
0
17
1
Order By: Relevance
“…Secondly, it was hypothesized that MNPSNPs are available in the implantation area. And thirdly, based on the results of previous in vitro and in vivo studies [26,53,54], an externally magnetized ferromagnetic implant material was supposed to be able to accumulate these nanoparticles at the implant surface in higher concentrations than the control. This would mean a safe use of MNPSNPs as future drug carrier system for implantassociated infection treatment.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Secondly, it was hypothesized that MNPSNPs are available in the implantation area. And thirdly, based on the results of previous in vitro and in vivo studies [26,53,54], an externally magnetized ferromagnetic implant material was supposed to be able to accumulate these nanoparticles at the implant surface in higher concentrations than the control. This would mean a safe use of MNPSNPs as future drug carrier system for implantassociated infection treatment.…”
Section: Discussionmentioning
confidence: 99%
“…1.8 T, EM2, Magnet-Messtechnik J. Ballanyi, Germany) for 10 min. The detailed surgical procedure and magnetic field application, as well as the synthesis and characterization of the MNPSNPs, have already been described by Janßen et al [53].…”
Section: In Vivo Setupmentioning
confidence: 99%
See 3 more Smart Citations